> and that you're going to have to draw the line at some arbitrary cost/benefit limit. Well US is spending significantly more money than all other highly-deve

> and that you're going to have to draw the line at some arbitrary cost/benefit limit. Well US is spending significantly more money than all other highly-developed countries with (on average across population) worse outcomes than many of them to show for it. Also there is a lot of variance inside the country (i.e. the cost of identical treatment might vary wildly depending on health/insurance/etc. provider) making cost/benefit analysis semi meaningless.